Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China · Delayed Price · Currency is CNY 30.40
+0.21 (0.70%)
Sep 18, 2026, 3:04 PM CST
SHE:002294 Market Cap
SHE:002294 has a market cap or net worth of 33.69 billion as of September 18, 2026. Its market cap has decreased by -42.56% in one year.
Market Cap
33.69B
Enterprise Value
31.94B
Revenue
4.70B
Ranking
n/a
PE Ratio
50.69
Stock Price
30.40
ChartMarket Cap Chart
Since September 10, 2009, SHE:002294's market cap has increased from 5.64B to 33.69B, an increase of 497.40%. That is a compound annual growth rate of 11.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 33.69B | -39.01% |
| Dec 31, 2025 | 55.24B | 60.20% |
| Dec 31, 2024 | 34.48B | -3.26% |
| Dec 29, 2023 | 35.64B | -1.61% |
| Dec 30, 2022 | 36.23B | 19.87% |
| Dec 31, 2021 | 30.22B | 3.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Huadong Medicine | 45.86B |
| China Resources Sanjiu Medical & Pharmaceutical | 39.67B |
| Beijing Tongrentang | 31.85B |
| Humanwell Healthcare (Group) | 30.02B |
| Dong-E-E-Jiao | 29.36B |
| Changchun High-Tech Industry (Group) | 29.06B |
| Dizal (Jiangsu) Pharmaceutical | 25.93B |
| Apeloa Pharmaceutical Co.,Ltd | 25.43B |